Sumeray Mark
Insider CIK 1527134 · AEGR Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-08-04 | 2015-08-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-04-01 | 2015-04-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-04-01 | 2015-04-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2014-12-31 | 2015-01-05 | 65,000 | — | $0 | 65,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2014-04-01 | 2014-04-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2014-03-14 | 2014-03-18 | 2,000 | — | $0 | 113,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2014-03-14 | 2014-03-18 | 800 | $51.98 | $41.6K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2014-03-14 | 2014-03-18 | 900 | $51.31 | $46.2K | 800 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2014-03-14 | 2014-03-18 | 300 | $49.69 | $14.9K | 1,700 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2014-03-14 | 2014-03-18 | 2,000 | $13.01 | $26.0K | 2,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2014-02-14 | 2014-02-18 | 2,000 | — | $0 | 115,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2014-02-14 | 2014-02-18 | 500 | $64.52 | $32.3K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2014-02-14 | 2014-02-18 | 1,500 | $63.14 | $94.7K | 500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2014-02-14 | 2014-02-18 | 2,000 | $13.01 | $26.0K | 2,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2014-01-16 | 2014-01-21 | 2,000 | — | $0 | 117,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2014-01-16 | 2014-01-21 | 100 | $59.51 | $6.0K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2014-01-16 | 2014-01-21 | 1,900 | $58.59 | $111.3K | 100 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2014-01-16 | 2014-01-21 | 2,000 | $13.01 | $26.0K | 2,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2014-01-02 | 2014-01-06 | 1,000 | — | $0 | 119,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2014-01-02 | 2014-01-06 | 400 | $70.22 | $28.1K | 600 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2014-01-02 | 2014-01-06 | 1,000 | $13.01 | $13.0K | 1,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2014-01-02 | 2014-01-06 | 600 | $71.41 | $42.8K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-12-16 | 2013-12-17 | 2,000 | — | $0 | 120,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-12-16 | 2013-12-17 | 200 | $67.38 | $13.5K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-12-16 | 2013-12-17 | 1,800 | $66.23 | $119.2K | 200 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-12-16 | 2013-12-17 | 2,000 | $13.01 | $26.0K | 2,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-12-02 | 2013-12-04 | 3,000 | — | $0 | 122,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-12-02 | 2013-12-04 | 600 | $71.20 | $42.7K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-12-02 | 2013-12-04 | 3,000 | $13.01 | $39.0K | 3,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-12-02 | 2013-12-04 | 2,400 | $70.23 | $168.6K | 600 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-11-15 | 2013-11-19 | 2,000 | — | $0 | 125,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-11-15 | 2013-11-19 | 2,000 | $13.01 | $26.0K | 2,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-11-15 | 2013-11-19 | 1,011 | $75.89 | $76.7K | 500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-11-15 | 2013-11-19 | 489 | $74.93 | $36.6K | 1,511 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-11-15 | 2013-11-19 | 500 | $77.63 | $38.8K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-11-01 | 2013-11-05 | 3,500 | — | $0 | 127,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-11-01 | 2013-11-05 | 100 | $84.34 | $8.4K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-11-01 | 2013-11-05 | 2,000 | $83.59 | $167.2K | 100 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-11-01 | 2013-11-05 | 3,500 | $13.01 | $45.5K | 3,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-11-01 | 2013-11-05 | 1,400 | $82.76 | $115.9K | 2,100 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-10-15 | 2013-10-16 | 2,000 | — | $0 | 130,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-15 | 2013-10-16 | 1,000 | $79.95 | $80.0K | 1,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-15 | 2013-10-16 | 1,000 | $80.71 | $80.7K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-10-15 | 2013-10-16 | 2,000 | $13.01 | $26.0K | 2,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-10-07 | 2013-10-08 | 3,500 | — | $0 | 132,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-07 | 2013-10-08 | 700 | $94.81 | $66.4K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-10-07 | 2013-10-08 | 3,500 | $13.01 | $45.5K | 3,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-07 | 2013-10-08 | 1,265 | $93.23 | $117.9K | 700 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-07 | 2013-10-08 | 1,535 | $92.37 | $141.8K | 1,965 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-09-16 | 2013-09-18 | 2,000 | — | $0 | 136,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-09-16 | 2013-09-18 | 500 | $89.73 | $44.9K | 900 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-09-16 | 2013-09-18 | 100 | $92.51 | $9.3K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-09-16 | 2013-09-18 | 2,000 | $13.01 | $26.0K | 2,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-09-16 | 2013-09-18 | 800 | $90.41 | $72.3K | 100 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-09-16 | 2013-09-18 | 600 | $88.50 | $53.1K | 1,400 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-08-16 | 2013-08-20 | 2,000 | — | $0 | 138,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-08-16 | 2013-08-20 | 400 | $90.08 | $36.0K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-08-16 | 2013-08-20 | 2,000 | $13.01 | $26.0K | 2,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-08-16 | 2013-08-20 | 900 | $88.01 | $79.2K | 1,100 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-08-16 | 2013-08-20 | 700 | $88.81 | $62.2K | 400 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-07-15 | 2013-07-16 | 2,000 | — | $0 | 140,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-07-15 | 2013-07-16 | 758 | $78.95 | $59.8K | 742 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-07-15 | 2013-07-16 | 500 | $77.28 | $38.6K | 1,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-07-15 | 2013-07-16 | 2,000 | $13.01 | $26.0K | 2,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-07-15 | 2013-07-16 | 742 | $79.60 | $59.1K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-06-17 | 2013-06-19 | 6,000 | — | $0 | 142,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-06-17 | 2013-06-19 | 1,000 | $65.36 | $65.4K | 2,400 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-06-17 | 2013-06-19 | 791 | $63.86 | $50.5K | 3,400 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-06-17 | 2013-06-19 | 1,809 | $63.05 | $114.1K | 4,191 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-06-17 | 2013-06-19 | 900 | $66.67 | $60.0K | 1,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-06-17 | 2013-06-19 | 100 | $68.44 | $6.8K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-06-17 | 2013-06-19 | 1,400 | $67.73 | $94.8K | 100 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-06-17 | 2013-06-19 | 6,000 | $13.01 | $78.1K | 6,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-05-15 | 2013-05-17 | 6,000 | — | $0 | 148,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-05-15 | 2013-05-17 | 6,000 | $13.01 | $78.1K | 6,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-05-15 | 2013-05-17 | 6,000 | $47.32 | $283.9K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-04-22 | 2013-04-24 | 6,000 | — | $0 | 154,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-04-22 | 2013-04-24 | 6,000 | $13.01 | $78.1K | 6,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-04-22 | 2013-04-24 | 2,150 | $41.36 | $88.9K | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-04-22 | 2013-04-24 | 3,850 | $40.40 | $155.5K | 2,150 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2013-04-01 | 2013-04-03 | 27,500 | — | $0 | 27,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2013-01-02 | 2013-01-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer deriv | 2013-01-02 | 2013-01-04 | 20,000 | — | $0 | 0 | SEC↗ |